Who Will Win Ampyra Patent Fight - Acorda Or Kyle Bass?

The decision on inter partes review related to Acorda Therapeutics Inc.'s (ACOR) Ampyra is expected this month.

from RTT - Biotech http://ift.tt/2mKxyGq
via IFTTT